Antimicrobial Resistance in Escherichia coli

Microbiology Spectrum
Laurent PoirelStefan Schwarz

Abstract

Multidrug resistance in Escherichia coli has become a worrying issue that is increasingly observed in human but also in veterinary medicine worldwide. E. coli is intrinsically susceptible to almost all clinically relevant antimicrobial agents, but this bacterial species has a great capacity to accumulate resistance genes, mostly through horizontal gene transfer. The most problematic mechanisms in E. coli correspond to the acquisition of genes coding for extended-spectrum β-lactamases (conferring resistance to broad-spectrum cephalosporins), carbapenemases (conferring resistance to carbapenems), 16S rRNA methylases (conferring pan-resistance to aminoglycosides), plasmid-mediated quinolone resistance (PMQR) genes (conferring resistance to [fluoro]quinolones), and mcr genes (conferring resistance to polymyxins). Although the spread of carbapenemase genes has been mainly recognized in the human sector but poorly recognized in animals, colistin resistance in E. coli seems rather to be related to the use of colistin in veterinary medicine on a global scale. For the other resistance traits, their cross-transfer between the human and animal sectors still remains controversial even though genomic investigations indicate that extended-sp...Continue Reading

References

May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Dec 1, 1995·Microbiology·G D Recchia, R M Hall
Jun 1, 1997·Trends in Microbiology·J Davies, G D Wright
Jun 6, 1998·Journal of Molecular Biology·D FourmyJ D Puglisi
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·R H GriffeyS T Crooke
Jan 20, 2000·Antimicrobial Agents and Chemotherapy·K KeyesM D Lee
Apr 27, 2000·Journal of Bacteriology·R ChalmersP Crellin
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·A CloeckaertE Chaslus-Dancla
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Alain PhilipponGeorge A Jacoby
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Diana E WaturangiWalter Erdelen
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Vincent Perreten, Patrick Boerlin
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Marc GalimandThierry Lambert
Dec 3, 2003·The Journal of Antimicrobial Chemotherapy·Maren Blickwede, Stefan Schwarz
Mar 26, 2004·Nature Reviews. Microbiology·James B KaperHarry L Mobley
Nov 13, 2004·FEMS Microbiology Reviews·Stefan SchwarzAxel Cloeckaert
Apr 26, 2005·International Journal of Antimicrobial Agents·Katie L HopkinsE John Threlfall
May 27, 2005·The Journal of Antimicrobial Chemotherapy·Johann D D PitoutLaurent Poirel
Jun 21, 2005·Emerging Infectious Diseases·Bruno González-ZornLucas Domínguez
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·M GalimandT Lambert
Oct 22, 2005·International Journal of Medical Microbiology : IJMM·James R Johnson, Thomas A Russo
Nov 5, 2005·Applied and Environmental Microbiology·Patrick BoerlinMarie Archambault
May 25, 2006·The Journal of Antimicrobial Chemotherapy·Rebeccah M TravisPatrick Boerlin
Mar 14, 2007·The Journal of Antimicrobial Chemotherapy·Lin ChenHong-Xia Jiang
May 29, 2007·The Journal of Antimicrobial Chemotherapy·Lars Hestbjerg HansenSøren Johannes Sørensen
Jun 1, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·G M KikuviC Kehrenberg
Dec 25, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L PoirelP Nordmann
Feb 23, 2008·Current Opinion in Microbiology·Nahum Y ShpigelIlan Rosenshine
Mar 7, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Daniela CostaCarmen Torres
Mar 28, 2008·Veterinary Microbiology·Marianne SundeJannice Schau Slettemeås

❮ Previous
Next ❯

Citations

Jun 5, 2019·Antimicrobial Agents and Chemotherapy·Laura VinuéDavid C Hooper
Jun 19, 2019·Antimicrobial Agents and Chemotherapy·Nicolas KiefferLaurent Poirel
Dec 7, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Juan Valencia-BaccaNilton Lincopan
Sep 12, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Marcelina OsińskaAleksandra Trościańczyk
Nov 9, 2018·Viruses·Honghui LiuSylvain Moineau
Nov 14, 2019·International Journal of Environmental Research and Public Health·Chidozie Declan Iwu, Anthony Ifeanyi Okoh
May 15, 2020·International Journal of Environmental Research and Public Health·Jacek PiatekHenning Sommermeyer
Jan 30, 2019·Frontiers in Microbiology·Paula Signolfi CyoiaRenata Katsuko Takayama Kobayashi
Apr 30, 2020·Animals : an Open Access Journal From MDPI·Fabrizio BertelloniBarbara Turchi
Jun 20, 2020·Expert Opinion on Drug Discovery·Mateus Sá Magalhães SerafimVinícius Gonçalves Maltarollo
Nov 1, 2020·MicrobiologyOpen·Katrin ZurfluhRoger Stephan
Feb 23, 2021·Frontiers in Microbiology·Marketa NykrynovaHelena Skutkova
Mar 20, 2021·Travel Medicine and Infectious Disease·Samantha Dos Santos Tufic-GaruttiKáris Maria de Pinho Rodrigues
Mar 13, 2021·International Journal of Environmental Health Research·Tintswalo BaloyiLise Korsten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Therapeutic Advances in Infectious Disease
Mercedes Delgado-ValverdeJesús Rodríguez-Baño
Enfermedades infecciosas y microbiología clínica
Luis Martínez-Martínez, Juan José González-López
Mikrobiyoloji bülteni
Ozgen Köseoğlu
© 2022 Meta ULC. All rights reserved